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SH-SY5Y cellsa b s t r a c t
MicroRNA (miRNA) regulates expression of protein coding genes and has been implicated in diverse
cellular processes including neuronal differentiation, cell growth and death. To identify the role of
miRNA in neuronal differentiation, SH-SY5Y and IMR-32 cells were treated with dopamine cocktail
and retinoic acid to induce differentiation. Detection of miRNAs in differentiated cells revealed that
expression of many miRNAs was altered signiﬁcantly. Among the altered miRNAs, human brain
expressed miR-432 induced neurite projections, arrested cells in G0–G1, reduced cell proliferation
and could signiﬁcantly repress NESTIN/NES, RCOR1/COREST and MECP2. Our results reveal that
miR-432 regulate neuronal differentiation of human neuroblastoma cells.
 2014 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction To maintain neuronal identity, expressions of genes are regu-MicroRNA (miRNA) belongs to a class of small non-coding
single stranded RNA and regulates expression of protein coding
genes. Mature miRNA is about 21–25 nucleotides long and is
the ﬁnal processed product of primary transcript (pri-miRNA) of
miRNA locus. MiRNA generally binds with 30-untranslated regions
(30-UTR) of the gene (target) in human. They suppress expression
of targets either by degrading mRNA or repressing translation
[1]. It has been predicted that miRNA may target most of
human protein coding genes [2], although experimentally vali-
dated targets are limited. Only about 2500 genes in human have
been experimentally validated [3–5]. Validated targets of miRNAs
modulate various biological processes like neuronal differentiation
[6,7], cell death [8], cell cycle and cell proliferation [9].lated by transcription factors and miRNAs. Transcription repressor
REST and its co-repressor complex containing histone deacetylases,
methyl CpG binding protein MECP2, and RCOR1 bind with a con-
served 23-bp repressor element (RE1) to suppress the transcription
of neuronal genes in non-neuronal cells. REST also recruits anti-
neural factor like small C-terminal domain phosphatase1 (SCP1)
at RE1. SCP1 is repressed in neuronal cells by miR-124 during neu-
rogenesis. But miR-124 expression is absent in non-neuronal cells,
even neuronal progenitor cells. A negative feedback loop operates
between miR-124 and SCP1/REST pathway that decides neural or
anti-neural behavior of the cell [10,11].
In spite of several evidences for altered miRNA expression dur-
ing neuronal differentiation, it is expected that additional miRNAs
may also be critical for neuronal identity. Expression of many miR-
NA alters during differentiation, but role of miRNA in inducing
neuronal differentiation is mostly unknown.
Human neuroblastoma SH-SY5Y cells treated with dopamine
cocktail (DC) and retinoic acid (RA), elicited neurite projections
and differentiate into neuron-like cells. In search of miRNAs, whose
expression could alter during neuronal differentiation, we
identiﬁed that expression of 16 miRNAs were increased and 12
miRNAs were decreased in differentiated cells. We characterized
in detail the novel miR-432, whose expression was increased after
treatment with DC and RA. We also demonstrate that ectopic
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miR-432 reduced the neurogenesis. Besides, miR-432 could repress
NESTIN, MECP2 and RCOR1. We also observed that miR-432 in-
duced neurogenesis in human IMR-32 cells. This result shows that
miR-432 may behave as a regulator in neuronal differentiation by
regulating stem cell modulating genes in human neuroblastoma
cells.
2. Materials and methods
2.1. Cell culture and differentiating conditions
Human derived neuroblastoma cells SH-SY5Y and IMR-32 were
maintained in DMEM (HiMedia, India), 10% (v/v) FBS (Biowest,
France), 1% (v/v) PS at 37 C in humidiﬁed, 5% CO2. Cells were pla-
ted at the concentration of 104/cm2 for neuronal differentiation.
We differentiated the SH-SY5Y and IMR-32 cells with the fol-
lowing cocktail: 10 ng/ml a-FGF, 250 lM IBMX, 200 nM TPA,
50 lM forskolin, 5 lM dopamine (Sigma) for 7 days as described
earlier [12].
We also differentiated neuroblastoma cells with RA as pub-
lished elsewhere [13]. Next day after seeding, cells were incubated
with RA (sigma) at a ﬁnal concentration of 10 lM. The differentiat-
ing mediums also contain 10% B27 growth supplement (Invitro-
gen) for both cases. All treatments were performed in dark.
2.2. Flow cytometry
Proportion of SH-SY5Y cells at different phases of cell cycle was
determined using the procedures described earlier [14].
2.3. RNA preparation
Total RNA was extracted from cultured cells using Trizol Re-
agent (Invitrogen, USA) according to manufacturer’s protocol.
RNA samples were quantitated using Biophotometer (Eppendorf,
Germany).
2.4. Quantitative real-time reverse transcription PCR (qRT-PCR) for
mRNA and microRNAs
Methods used for detection of miRNA expression using stem
loop speciﬁc primers and expression of protein coding genes using
gene speciﬁc primers were similar to that has been published ear-
lier [15,16]. List of primers for cloning pre-miR-432, 30-UTR of the
target genes and gene expression studies and their ensemble ID are
shown in Supplementary Table S2A. The miR-132 mimic (ambion)
was commercially obtained.
2.5. Immunocytochemistry
The method for immunocytochemistry was as described else-
where [14] except the secondary anti body goat anti-mouse IgG-
Alexa 488, 1:300, Invitrogen, USA was used. Neurite number was
quantiﬁed using published method [17].
2.6. Western blot analysis
Western blot analysis was carried out using standard methods
described earlier [15]. List of antibodies and their sources are
shown in Supplementary Table S2B.
2.7. Cell proliferation assay
Cell proliferation assay was determined bymeasuring the incor-
poration of BrdU into DNA following the protocol provided by themanufacturer of the KIT (Calbiochem, Cat. No. QIA58) and de-
scribed earlier [14].
2.8. Luciferase reporter assays
The predicted recognition site of miR-432 at 30-UTR of NES,
MECP2 and RCOR1 were cloned into the pmiR-Report luciferase
vectors between the Hind III and MluI site, immediately 30 down-
stream of the Renilla luciferase gene as described earlier [15].
2.9. Image processing
Images of histograms, Western blots and cell cycle distributions
were prepared with the help of Adobe photoshop CS2 software.
2.10. Statistical analysis
Data are presented as mean ± S.D. of three independent experi-
ments. Statistical signiﬁcance of differences between groups was
determined by Student’s unpaired t-test with the help of Graphpad
Software, QuickCalcs, (http://www.graphpad.com/quickcalcs/in-
dex.cfm) when two groups were present.
3. Results
3.1. Differentiation of SH-SY5Y cells by dopamine cocktail (DC) and
retinoic acid (RA) treatment
Neurite outgrowth was apparent after 3-day with DC and RA
treatment in SH-SY5Y cells. Though the number of roots was not
signiﬁcantly altered at day 7 but the frequency and length of neu-
rites increased with the duration of chemical treatment. At day 7,
>70% of cells exhibited at least 1 neurite that extended in length
more than 1 cell-body from cell periphery. Treated cells expressed
neuronal markers TUBB3 but showed low level of expression of
progenitor marker NES at day 7. Similarly, control SH-SY5Y cells
expressed NES at day 0 to day 7 but did not express TUBB3 at
day 7 (Fig. 1A and Supplementary Fig. S1A). Expression (mRNA le-
vel) of additional neuronal markers (CNR1, MAP2, SYT5, BDNF,
CHAT, RARa and TH) was increased whereas mRNA expression of
neural progenitor markers POU5F1, NES and NANOG was de-
creased signiﬁcantly at day 3 and day 7 after DC (Fig. 1B) and RA
(Fig. 1C) treatment. DC induced adrenergic phenotype that was
associated with TH gene upregulation, whereas RA induced cholin-
ergic phenotype that has been marked by CHAT and RARa gene
upregulation in SH-SY5Y cells [18–20]. Though expression of CHAT,
RARa and TH has been upregulated in presence of both DC and RA
reagents but increased expression of CHAT and RARawas higher in
presence of RA compared to TH expression. Increased expression of
TH in RA treated cells was also reported earlier as TH was regulated
by Retinoic acid receptor [21]. Similarly increased expression of TH
was higher in presence of DC compared to RA.
Western blot analysis also revealed that NES protein expression
decreased at day 7 while the expression of TUBB3 was elevated at
day 7 after treatment with DC and RA (Supplementary Fig. S1B).
We also tried to ﬁnd out the status of two other neurodevelopment
associated proteins MECP2 and RCOR1 in DC and RA treated cells.
RCOR1 protein expression was reduced at day 7 of DC and RA trea-
ted cells but this reduction was less compared to NES protein
expression in DC and RA treated cells. But MECP2 expression was
increased at day 7 of DC and RA treatment (Supplementary
Fig. S1C) as reported earlier [22]. Expression of progenitor markers
and neuronal markers correlated with neurite outgrowth. Further,
incorporation of BrdU in DNA, a measure for cell proliferation, was
reduced signiﬁcantly by treatment of DC and RA at day 3 and day 7
(Fig. 1D). Thus, treatment with DC and RA induce neuronal
Fig. 1. DC and RA induced neuronal differentiation in neuroblastoma SH-SY5Y cells. (A) Photomicrograph shows morphology of SH-SY5Y cells following treatment with DC
and RA at day 7. SH-SY5Y cells were immunostained with neuronal progenitor marker NES (green) at day 0 (upper panel), neuronal marker TUBB3 (green) at day 7 in presence
of DC (middle panel) and RA (lower panel). Nuclei were counterstained with DAPI (blue). Scale bar was 50 lm. The images were acquired by an apotome ﬂuroscence
microscope using a 20 objective lens. The percentage of neuron-like cells in each biological replicate was analyzed and averaged by at least 15 images; each image of 20
magniﬁcation typically captures 100–200 SH-SY5Y cells. Neurite outgrowths, staining positively for TUBB3 and longer than 30 lm are counted for DC and RA treated cells. Bar
graph displayed number of neurites per cell and average length of neurite (P30 lm) following the treatments with DC and RA. Very few control SH-SY5Y cells were
continuously differentiated but their neurite outgrowths were not longer than 30 lm and their neurites were not positive for TUBB3. Neurites were manually counted using
ImageJ and the NeuronJ plugin. (B) Expression of neuronal and progenitor markers by quantitative real-time PCR at day 3 and 7 of DC treatment. Expression of the genes was
normalized with expression of beta-actin and compared with the values obtained at day ‘‘0’’. (C) Expression of marker genes at day 3 and 7 of RA treatment. (D) BrdU
incorporation, at day 3 and 7 by treatment with DC and RA (n = 4). Symbols ⁄, ⁄⁄ and ⁄⁄⁄ represent statistical signiﬁcance P 6 0.05, P 6 0.01 and P 6 0.001respectively. Error
bars represent mean ± S.D. of data from three biological replicates for all experiments described above.
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investigators.
3.2. Altered micro RNA expressions in SH-SY5Y cells treated with DC
and RA
Role of miRNAs in neuronal development, neurogenesis, and
maintenance of pluripotency has been reviewed recently [23,24].
Compiling data from various publications, we collected 99 miRNAs
that had been reported to alter expression during neurogenesis/neuronal development and differentiated neurons (Supplementary
Table S1A). Increased expression of 21 miRNA is reported in more
than one publication; enhanced expression of miR-124, miR-125b
and miR-9 is reported in 11, 10 and 7 publications respectively.
Expression of miR-19a has been reported to decrease in 2 experi-
ments and increase in 1 experiment. Result for 9 miRNA was oppo-
site in two publications. Expression of other miRNAs was reported
only once.
We have chosen 96 miRNAs from our earlier studies [15,25],
bioinformatics analysis (http://miRNAMap.mbc.nctu.edu.tw/) and
Fig. 2. miRNA expression using Q-RT PCR for mature miRNAs using stem-loop miRNA primers in differentiated SH-SY5Y cells. (A) Expression of miRNA in cells treated with
DC for 3 and 7 days (B) Expression of miRNA in cells treated with RA for 3 and 7 days. In both the cases (A, B) expression was normalized with the expression of miR-301. Error
bars represent mean ± S.D. of three independent experiments. Symbols ⁄, ⁄⁄, ⁄⁄⁄ and ⁄⁄⁄⁄ represent statistical signiﬁcance P 6 0.05; P 6 0.01, P 6 0.001and P 6 0.0001
respectively.
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database) revealed that miR-9-1, miR-9-2, miR-9-3, miR-124,
miR-432 are highly enriched in brain. The result is shown in the
Supplementary Table S1B [26–28]. It was evident that these 96
miRNAs are differentially expressed in brain.
Expression of these 96 miRNAs was determined at day 3 and
day 7 of treatments with DC and RA. Among these miRNAs,
expression of 16 miRNAs was increased signiﬁcantly, while
expression of 12 miRNAs was decreased by both treatments for
7 days. Expression of miR-145 was decreased signiﬁcantly at day
3 but expression was increased at day 7. Expressions of let-7a,
miR-100, miR-124, miR-125b, miR-137 and miR-34a have been re-
ported to increase in other publications [29,30]. Expression of
miR-16 has also been reported to increase [31]. Expression of
miR-132 and miR-15b was also increased in our experimental con-
dition. However, some of the miRNAs decreased in our experimen-
tal conditions has been reported to decrease (Supplementary
Table S1A).
We identiﬁed increased expression of miR-126, miR-127, miR-
132, miR-125a and miR-432 and decreased expression of miR-
146a, miR-150, miR-154, miR-194, miR-205, miR-219, miR-296
and miR-342-5p after both the treatments. These miRNAs have
not been reported earlier to alter during neurogenesis. Expression
of mir-107, mir-214, mir-199a⁄, mir-218, mir-135a, mir-135b was
not changed signiﬁcantly. Few miRNAs showed opposite trend of
expression with DC versus RA treatment. Expression of miRNAs
that are signiﬁcantly upregulated more than two folds is shown
in Fig. 2A and Fig. 2B. Summary of expression of other miRNAs is
shown in Supplementary Fig. S2A, S2B and Supplementary
Table S1C. Since no data was available for miR-432 and at least
in one study it has been shown to express in brain only, we have
concentrated on the role of miR-432 on neurogenesis/differentia-
tion. Induction of neurite outgrowths in Neuro2A (mouse neuro-
blastoma cell line) cells after treatment with DC and RA has been
observed. Expression of miR-432 was also increased in this cell
model of differentiation (data not shown). Thus expression of
miR-432 increased in human and mouse cells during neuronal
differentiation.3.3. Ectopic expression of miR-432 enhances the formation of neurites
and induces the expression of neuronal markers in SH-SY5Y cells
The hypothesis that miR-432 may promote neuronal differenti-
ation was directly addressed by transfecting pre-mir-432 cloned in
vector U61 and empty vector U61 (control) into SH-SY5Y cell line.
Expression of pre-mir-432 increased the expression of mature
miR-432 as detected by real time PCR and stem-loop speciﬁc PCR
primers (Supplementary Fig. S3A). It was observed that number of
TUBB3 positive cells with neurite outgrowth signiﬁcantly increased
in cells expressing exogenous pre-mir-432 (Fig. 3B) after 4 days of
transfection compared to empty vector transfected cells (Fig. 3A).
Inhibition of miR-432 expression by treatment with phosphoro-
thioate antisense mature miR-432 sequence (anti-miR-432) in cells
expressing pre-mir-432 resulted in inhibition of increased neurite
outgrowth (Fig. 3C). We also checked that expression of mature
miR-432 expression was downregulated in presence of anti-miR-
432 (Supplementary Fig. S3B). Inhibition of endogenous miR-432
by anti-miR-432 induced proliferation of SH-SY5Y cells as deter-
mined by BrdU assay (Supplementary Fig. S3C).
Exogenous expression of miR-432 in DC and RA treated cells
signiﬁcantly increased average neurite length by 6 and 3.5 lm
respectively 4 days posttransfection. But ectopic expression of
miR-432 in DC and RA treated cells does not signiﬁcantly alter
the number of neurites per cell. We also knocked down expression
of miR-432 in presence of DC and RA by anti-miR-432, and assayed
neurite outgrowth 4 days posttransfection. Knockdown of miR-432
does not reduce the number of neurites per cell but signiﬁcantly
reduced average length of neurite by 7.5 lm in DC treated cells
but only 2.5 lm in RA treated cells (Supplementary Fig. S3D).
So, there are other endogenous factors that are necessary for induc-
tion and maintenance of neurite outgrowth in presence of DC and
RA treated cells. We next measured the expression of neuronal
markers CNR1, MAP2, SYT5, BDNF, CHAT, RARa and TH mRNA
expression in miR-432 transfected SH-SY5Y cells (Fig. 3D). Expres-
sion of these genes was increased more than 3-fold in the presence
of miR-432. These results show that enforced miR-432 expression
promotes the neuron-speciﬁc protein expression in SH-SY5Y cells.
Fig. 3. Role of miR-432 in neuronal differentiation of SH-SY5Y cells. (A) TUBB3 positive cells among the vector transfected SH-SY5Y cells. (B) Neurite outgrowth and TUBB3
positive cells among cells exogenously expressing pre-mir-432 after 4 days of transfection. Nuclei were stained with DAPI. (C) Neurite projections and TUBB3 positive cells
among cells exogenously co-expressing pre-mir-432 and anti-miR-432. The side panel shows the number of neurites per cell (top graph) and average (n = 3) length of neurites
(bottom graph). Neurite outgrowths which are staining positively for TUBB3 and possessing neurites longer than 30 lm are counted. The images were acquired by an
apotome ﬂuroscence microscope using a 20 objective lens for all experiments (Fig. 3A–C). The percentage of neuron-like cells in each biological replicate was analyzed and
averaged by at least 15 images; each image of 20 magniﬁcation typically captures 100–200 SH-SY5Y cells. Neurites were manually counted using ImageJ and the NeuronJ
plugin. (D) Expression (mRNA) of neuronal markers CNR1, MAP2, SYT5, BDNF, CHAT, RARa and TH normalized with BETA-ACTIN expression in presence of pre-miR-432 and
cotransfection of miR-432 and anti-miR-432. Error bars represent mean ± S.D. of three biological independent experiments. Symbols ⁄, ⁄⁄ and ⁄⁄⁄ represent statistical
signiﬁcance P 6 0.05; P 6 0.01 and P 6 0.001 respectively.
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of miR-432 is cell line speciﬁc; we used another human neuroblas-
toma cell line IMR-32. We used DC and RA reagents to induce neu-
ronal differentiation of IMR-32 cells. The TUBB3 positive neurite
ourgrowth was observed at day 3 and we followed the neuronal
differentiation process up to 7 days. During this process, we ob-
served a continuous change in morphology marked by the appear-
ance of neurite outgrowth (Supplementary Fig. S4A) as well as
upregulation of neuronal markers and downregulation of progeni-
tor markers was also observed (Supplementary Fig. S4B). Moreover
miR-432 expression was increased signiﬁcantly during DC and RA
treatment at day 3 and day 7 (Supplementary Fig. S4C). We mea-
sured expression of mature miR-432 after 48hrs of transfection
in IMR-32 cell to determine its overexpression (Supplementary
Fig. S4D). Ectopic expression of miR-432 also signiﬁcantly induced
TUBB3 positive neurites in IMR-32 cell compared to vector trans-
fected cells. Notably, cotransfection of miR-432 and anti-miR-432
reduced TUBB3 positive neurons signiﬁcantly in IMR-32 cells com-
pared to miR-432 transfected IMR-32 cells (SupplementaryFig. S4E). So, the effect of miR-432 in neuronal differentiation of
IMR-32 is quiet similar to SH-SY5Y cells.
3.4. MiR-432 expression inhibits cell proliferation and arrests SH-SY5Y
cells at G0–G1 phase of the cell cycle
If miR-432 induces neuronal differentiation in SH-SY5Y cells, it
is expected that miR-432 should inhibit the cell proliferation.
Determination of cell proliferation by BrdU incorporation revealed
that exogenous expression of pre-mir-432 signiﬁcantly decreased
the fraction of cells in S phase, compared to control vector transfec-
ted cells after 48hr of transfection. Such decrease in proliferation
was rescued when exogenous expression was inhibited by anti-
miR-432 (Fig. 4A).
To investigate the mechanism of inhibition of cell proliferation,
we determined the effect of miR-432 on SH-SY5Y cell cycle by ﬂow
cytometry. Cell cycle distribution showed that cells in G0–G1
phase increased in presence of miR-432 than empty vector and
anti-miR-432 (Fig. 4B). Western blot analysis also revealed that
Fig. 4. Effects of pre-miR-432 expression on cell proliferation and cell cycle. (A) Incorporation of BrdU, in SH-SY5Y cells expressing control vector, pre-miR-432 and pre-miR-
432 plus anti-miR-432 together. No signiﬁcant difference in BrdU incorporation was observed after transfection of vector and SH-SY5Y cells growing in presence of 10%
serum. (B) Distribution of SH-SY5Y cells expressing pre-miR-432 and pre-miR-432 plus anti-miR-432 together by FACS. Proportion of cells at G1, S and G2 was determined by
Modﬁt analysis. (C) Expression of cell cycle inhibitor p27 in SH-SY5Y cells expressing pre-miR-432 and pre-miR-432 plus anti-miR-432 together detected by Western blot.
Intensity compared to b-actin was shown in right panel of representative immunoblot. Error bars represent mean ± S.D. of three biological independent experiments. All
experiments were performed thrice independently. Symbols ⁄ and ⁄⁄ represent statistical signiﬁcance P 6 0.05 and P 6 0.01 respectively.
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[32], was upregulated in cells expressing pre-mir-432 after 48hr of
transfection than vector transfected cells and cotransfection with
miR-432 and anti-miR-432 (Fig. 4C). Decreased incorporation of
BrdU in DNA, cell cycle block at G0–G1 and increased expression
of p27 by exogenous expression of miR-432 and inhibition of such
changes by anti-miR-432 show that miR-432 inhibits cell growth
in a condition where it induces neurogenesis/neuronal differentia-
tion in SH-SY5Y cells.
3.5. Mir-432 targets NES, RCOR1/COREST and MECP2 in SH-SY5Y cells
In order to investigate the neuronal differentiating property of
miR-432, we have searched three prediction tools (Microcosm,
TargetScan Release 5.2 and RNAhybrid) to identify the neuronal
differentiation associated target(s) of miR-432. As shown in
Fig. 5A. miR-432 has two putative binding sites in 30UTR of NES
gene (predicted by Microcosom, RNAhybrid algorithm), one site
in 30UTR of RCOR1 and one pairing in 30UTR of MECP2 gene (pre-
dicted by TargetScan 5.2 and RNAhybrid algorithm). MECP2 [33],
has two isoforms and the longer transcript is expressed in brain
[34]. Interestingly miR-432 has binding sites in this longer tran-
script (NM_004992). To examine the potential interaction between
miR-432 and these three target genes, 30UTR of these genes con-
taining binding sites of miR-432, was cloned into pMIR-REPORT
luciferase vector. Luciferase activity of 30-UTR of these genes has
been signiﬁcantly reduced in presence of miR-432 but such repres-
sion rescued after transfection of anti-miR-432 (Fig. 5B–D).
Furthermore, expression of NES, MECP2 and RCOR1 mRNA and
protein level was also reduced in presence of miR-432signiﬁcantly. But this reduction was rescued in presence of
cotransfection of pre-miR-432 and anti-miR-432 (Fig. 5E and F).
Overexpression of miR-132 mimic induced the expression of ma-
ture miR-132 in SH-SY5Y cells (data not shown) and it inhibited
MECP2 expression in RNA and protein level (Supplementary
Fig. S5A and S5B). Thus, both miR-132 and miR-432 repress MECP2
expression in SH-SY5Y cells.4. Discussion
Dopaminergic and cholinergic neuron loss is associated with
different neurodegenerative diseases [35,36]. Hence, we used two
reagents DC and RA that are known to induce dopaminergic and
cholinergic neurons respectively [37–40]. MiRNAs that are altered
in presence of two reagents may have some therapeutic roles for
treatment of neurodegenerative diseases. Hence, we differentiated
our cells with these two reagents to strengthen our ﬁndings. In-
creased expression of CNR1, MAP2, SYT5, BDNF, CHAT, RARa and
TH markers for neuronal cells [30] and decreased expression of
neuronal progenitor markers POU5F1, NES and NANOG were ob-
served in DC and RA treated cells. In addition, inhibition of cell pro-
liferation was observed in such condition. This result shows DC and
RA treatment induces neuronal differentiation in neuroblastoma
cell lines. Among 16 miRNAs, whose expression was increased at
day 7 by treatment with both the agents, increased expression of
let-7a, miR-100, miR-124, miR-125b, miR-134, miR-15b, miR-16,
miR-132, miR-125a, miR-137, miR-9, miR-9⁄ and miR-34a in
differentiated neuron has been reported earlier (Supplementary
Table S1A). We report here increased expression of miR-126,
Fig. 5. miRNA-432 targets NES, MECP2 and RCOR1. (A) Predicted recognition sites of miR-432 at 30UTRs of NES (two sites), RCOR1 and MECP2. (B) Reporter luciferase
activities in cells expressing the luciferase construct bearing the 30-UTRs of NES gene containing two binding sites of pre-mir-432 or pre-mir-432 plus anti-miR-432 in SH-
SY5Y cells. Luciferase activities in arbitrary unit were normalized with the values obtained in cells expressing the empty vector (without 30-UTR) and expressed as relative
luciferase activity. (C) Reporter luciferase activity of 30-UTR of MECP2 in SH-SY5Y cells expressing pre-mir-432 and anti-miR-432 together. (D) Reporter luciferase activitity of
30UTR of RCOR1 in SH-SY5Y cells expressing pre-mir-432 and anti-miR-432 together. In all cases (Fig. 5B–D), transfection efﬁciency was normalized by co-transfecting EGFP
and determining the ﬂuorescence of EGFP. (E) Endogenous expression of NES, MECP2 and RCOR1 mRNA in cells expressing either pre-mir-432 or pre-mir-432 and anti-miR-
432 together by real time PCR. Cells expressing empty vector was used as control. (F) Western blot showing signiﬁcant decrease in NES (n = 3, P = 0.0001), MECP2 (n = 3,
P = 0.002) and RCOR1 (n = 3 and P = 0.003) expression in SH-SY5Y cells transfected with miR-432 compared to empty vector only after 48 h posttransfection. No signiﬁcant
change was observed in miR-432 and anti-miR-432 cotransfected SH-SY5Y cells compared to empty vector (control) only. Average IOD obtained by comparing with beta-
actin was shown in adjacent bar diagram. Error bars of all experiments represent mean ± S.D. of three biological independent experiments. ⁄⁄, ⁄⁄⁄ and ⁄⁄⁄⁄ represent level of
signiﬁcance P 6 0.01, P 6 0.001 and P 6 0.0001 respectively. Triplicate experiments were performed for each set.
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identiﬁed that miR-432 induced neurite outgrowth as evident from
increased expression of neuronal markers, decreased expression of
neuronal progenitor markers, inhibition of cell proliferation and
cell cycle arrest in miR-432 over expressing cells.
Moreover expression of TH gene was induced more compared
to expression of CHAT and RARa in presence of miR-432 in
SH-SY5Y cells. So, miR-432 may induce expression of adrenergic
phenotype more compared to cholinergic phenotype. Knockdown
of miR-432 in SH-SY5Y cells couldn’t block neurite outgrowth,
but decrease average length of neurite more in DC treated cells
than RA treated cells. So, miR-432 along with other miRNAs is in-
volved in this complex process of neuronal differentiation in DC
and RA treated cells. Role of other miRNAs whose expression was
altered remains to be found out.
NES protein is a microtubule skeletal protein that is expressed
during the early neurogenesis but is almost absent in mature
neural cells [41–45]. MiR-125b target NES gene in neural stem cell
[46] and it can target NES gene in SH-SY5Y cells also (Data not
shown). Downregulation of NES gene after DC and RA treatmentmay be due to the combined effect of miR-432 and miR-125b. As
miR-432 and miR-125b could target this protein and thus expres-
sion of miR-432 and miR-125b could be a marker for neuronal
differentiation.
Expression of MECP2, another target of miR-432 is spatiotem-
porally regulated throughout human life as its loss or gain of func-
tion causes multiple neurodevelopment related disorders [47,48].
Loss of MECP2 function observed in Rett syndrome patients
(R106W or T158M) reduced dendritic and axonal length. BDNF
expression was regulated by wild type MECP2. MECP2 is targeted
by miR-132 and miR-483-5p in human brain [34,49]. In our exper-
iments, miR-132 and miR-432 suppress the expression of MECP2
in SH-SY5Y cells and expression of miR-132 and miR-432 were
upregulated in DC and RA treated cells at day 7. However, the
expression of their target gene MECP2 was also upregulated at
day 7 of DC and RA treated cells. Elevated level of MECP2 cannot
be solely explained from the increased expression of miR-132
and miR-432 in DC and RA treated cells. MECP2 is a predicted
target of most of the miRNAs altered in differentiated cells (data
not shown). Thus MECP2 in our experimental condition might be
E. Das, N.P. Bhattacharyya / FEBS Letters 588 (2014) 1706–1714 1713regulated by several miRNAs. Transcription factor NF-jB that was
upregulated in RA treated cells induced the expression level of
MECP2 during neuronal differentiation [50,51]. Factors other than
miR-132 and miR-432, may account for the observed increase in
the expression of MECP2 in DC and RA treated cells. Thus, miR-
432 might not modulate neuronal differentiation by targeting
MECP2 in SH-SY5Y cells.
RCOR1, target of miR-432, co-operating with transcriptional
repressor REST and other transcription regulators silences expres-
sion of neuronal genes in non-neuronal cells and neural stem cells
(NSCs) [52]. Recently, it has been shown that a large number of
genes might be regulated by RCOR1 independent of REST. RCOR1
occupies upstream to genes without REST binding sites in NSC
but not in neuronal cells [53,54]. Expression of miR-9/miR-9*,
miR-124 and miR-132 are regulated by REST. RCOR1 and REST
are target of miR-9* and miR-9 respectively [55]. It is also known
that miR-124 and miR-9* target BAF53a and involve in dendritic
outgrowth [7]. Downregulation of RCOR1 after DC and RA treat-
ment can be explained by corresponding increase in miR-432
expression.
In summary, we have shown here that expression of 16 miRNAs
was increased and 12 miRNAs was decreased in differentiated SH-
SY5Y cells compared to control neuroblastoma SH-SY5Y cells. Pos-
sibly, this is the ﬁrst report to show that human brain enriched
miR-432 [28] is involved in neuronal differentiation by targeting
neurogenesis related genes NES and RCOR1.
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